Failure of Medical Therapy in Pulmonary Arterial Hypertension Is There an Alternative Diagnosis?

被引:21
作者
Harch, Susan [1 ]
Whitford, Helen [2 ]
McLean, Catriona [1 ]
机构
[1] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3181, Australia
[2] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic 3181, Australia
关键词
VENOOCCLUSIVE DISEASE; PROSTACYCLIN; BOSENTAN; EDEMA;
D O I
10.1378/chest.08-2006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Despite the development of targeted therapies for pulmonary arterial hypertension (PAH), some patients fail to respond to medical therapy. There are a number of types of PAH, one of which is pulmonary venoocclusive disease (PVOD). Unlike other PAH types, the hallmark pathology of PVOD is fibrous occlusion of the small venules, potentially with arterial involvement. It was hypothesized that a lack of response to medical therapy in clinically diagnosed PAH can be explained by misdiagnosed PVOD. Methods: This study reviewed cases of 14 patients with clinically diagnosed PAH who had failed to respond to medical therapy and had lung tissue available from autopsy or explant. Control samples (n = 6) were obtained from lungs explanted for other causes, and at previous transthoracic echocardiogram excluded pulmonary hypertension. Comprehensive vessel morphometry was performed, and the clinical data reviewed. Results: Vessel analysis confirmed 86% of case patients had PVOD and 14% had arterial-only PAH (artPAH). In the PVOD case patients, significant pathology was present in all vessel types with similar obstructive, intimal fibrosis in the venules (p < 0.0001) and arterioles (p < 0.0001). This was considerably different from the intimal concentric laminar smooth muscle proliferation in the artPAH cases. There were no significant differences in clinical presentation between PVOD and artPAH case patients. Pulmonary edema was not observed in the PVOD cases. Conclusions: PVOD is an underdiagnosed and commonly, misdiagnosed cause of pulmonary hypertension, which may present with a failure to respond to medical therapy. Further studies on PVOD may help confirm whether a change in its classification as a type of PAH is necessary. (CHEST 2009; 135:1462-1469)
引用
收藏
页码:1462 / 1469
页数:8
相关论文
共 18 条
[1]   Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study [J].
Channick, RN ;
Simonneau, G ;
Sitbon, O ;
Robbins, IM ;
Frost, A ;
Tapson, VF ;
Badesch, DB ;
Roux, S ;
Rainisio, M ;
Bodin, F ;
Rubin, LJ .
LANCET, 2001, 358 (9288) :1119-1123
[2]   Venous and arterial changes in pulmonary veno-occlusive disease, mitral stenosis and fibrosing mediastinitis [J].
Chazova, I ;
Robbins, I ;
Loyd, J ;
Newman, J ;
Tapson, V ;
Zhdaov, V ;
Meyrick, B .
EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (01) :116-122
[3]   Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases [J].
Dorfmueller, Peter ;
Humbert, Marc ;
Perros, Frederic ;
Sanchez, Olivier ;
Simonneau, Gerald ;
Mueller, Klaus-Michael ;
Capron, Frederique .
HUMAN PATHOLOGY, 2007, 38 (06) :893-902
[5]   Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis [J].
Humbert, M ;
Maître, S ;
Capron, F ;
Rain, B ;
Musset, D ;
Simonneau, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (05) :1681-1685
[6]   Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis -: A clinicopathologic study of 35 cases [J].
Lantuejoul, Sylvie ;
Sheppard, Mary N. ;
Corrin, Bryan ;
Burke, Margaret M. ;
Nicholson, Andrew G. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (07) :850-857
[7]   Pulmonary veno-occlusive disease [J].
Mandel, J ;
Mark, EJ ;
Hales, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) :1964-1973
[8]   Prognosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines [J].
McLaughlin, VV ;
Presberg, KW ;
Doyle, RL ;
Abman, SH ;
McCrory, DC ;
Fortin, T ;
Ahearn, G .
CHEST, 2004, 126 (01) :78S-92S
[9]   Survival in primary pulmonary hypertension - The impact of epoprostenol therapy [J].
McLaughlin, VV ;
Shillington, A ;
Rich, S .
CIRCULATION, 2002, 106 (12) :1477-1482
[10]   Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease [J].
Palmer, SM ;
Robinson, LJ ;
Wang, AD ;
Gossage, JR ;
Bashore, T ;
Tapson, SF .
CHEST, 1998, 113 (01) :237-240